Civeo CORP

Market Movers (8-K)

See all →
NYSE
Civeo Corporation announced its second quarter 2026 financial results, reporting $180.0 million in revenues and a net loss of $2.5 million, while also successfully issuing $115.0 million in convertible senior notes.
Capital raise
NYSE
Civeo Corporation announced a six-year contract renewal for workforce accommodations in Western Canada and the pricing of a $100 million convertible senior notes offering.
Capital raise
NYSE
Civeo Corporation shareholders approved director elections, executive compensation, an equity plan amendment, and ratified the appointment of Ernst & Young LLP as auditor.
NYSE
Civeo Corporation has amended and restated its syndicated facility agreement, extending the maturity date to April 23, 2030, and increasing revolving loan commitments by $20.0 million.
NYSE
Civeo Corporation announced that Director Charles Szalkowski will retire from the Board at the 2026 annual general meeting of shareholders, with no disagreements cited.
NYSE
Civeo Corporation announced its fourth quarter and full year 2025 financial results, highlighted by record Australian revenues, improved Canadian margins, and an expanded share repurchase authorization.
Better than expected

Quarterly Earnings (10-Q)

See all →
NYSE
Civeo Corporation reported a 11% increase in Q2 2026 revenue to $180.0 million, driven by growth in Australia and Canada, while net loss attributable to Civeo narrowed to $2.5 million.
Capital raise
NYSE
Civeo Corporation reported a 20% increase in Q1 2026 revenue to $172.7 million, driven by the Qantac acquisition and higher occupancy in Canadian oil sands lodges.
NYSE
Civeo Corporation reported an improved net loss for Q3 2025, but its nine-month net loss widened significantly, driven by increased debt and Canadian segment weakness.
Capital raise
Worse than expected
NYSE
Civeo Corporation reported a net loss for the second quarter and first half of 2025, driven by significant revenue declines in its Canadian segment and increased operating costs, despite growth in Australia and a strategic acquisition.
Capital raise
Worse than expected
NYSE
Civeo Corporation's Q1 2025 results reveal a net loss and decreased revenue, influenced by reduced Canadian lodge occupancy and foreign exchange impacts, alongside strategic moves including an Australian acquisition and dividend suspension.
Worse than expected
NYSE
Civeo Corporation's third-quarter results show a net loss, impacted by reduced activity in Canada, while experiencing growth in Australia.
Worse than expected

Annual Reports (10-K)

NYSE
Civeo Corporation's 2024 results reveal a net loss despite revenue near \$700 million, while the company strategically expands in Australia through a \$67 million acquisition.
Worse than expected
NYSE
Civeo Corporation's 2023 annual report shows a slight revenue increase and improved operating income, despite challenges from fluctuating commodity prices and global economic conditions.
Better than expected

Insider Trading (Form 4)

See all →
NYSE
Civeo Corporation Director Richard A. Navarre acquired 1,232 common shares as part of an annual board retainer grant.
NYSE
Civeo Corporation Director Richard A. Navarre was granted 3,624 restricted common shares as part of the company's equity incentive plan.
NYSE
Director C. Ronald Blankenship acquired 3,624 restricted common shares of Civeo Corp as part of an equity compensation plan.
NYSE
Director Jeffrey Scofield acquired 3,624 restricted common shares of Civeo Corp as part of an equity compensation plan.
NYSE
Civeo Corporation Director Daniel B. Silvers was granted 3,624 deferred shares as part of an equity compensation plan.
NYSE
Director Timothy O. Wall was granted 3,624 restricted common shares of Civeo Corporation as part of the company's equity participation plan.

Proxy Statements (Def-14A)

NYSE
Civeo Corporation announced its 2026 Annual General Meeting of Shareholders, set for May 27, 2026, to elect directors, approve executive compensation, and amend its Equity Participation Plan.
NYSE
Civeo Corporation releases its proxy statement for the 2025 Annual General Meeting, outlining key proposals and showcasing a successful 2024 marked by revenue growth and shareholder returns.
Better than expected
NYSE
Civeo Corporation's upcoming annual general meeting will address key proposals including board declassification and amendments to preferred share terms, alongside routine director elections and executive compensation votes.

Schedule 13D - Activist Investments

See all →
NYSE
Engine Capital and its affiliates have disclosed a series of share sales in Civeo Corp, reducing their aggregate beneficial ownership to 6.3%.
NYSE
Engine Capital and its affiliates have reduced their beneficial ownership in Civeo Corp to 7.9% through recent sales of common stock.
Worse than expected
NYSE
Engine Capital and Civeo Corp have entered a Cooperation Agreement, leading to the appointment of two Engine Capital nominees to Civeo's Board of Directors.
NYSE
Engine Capital and its affiliated entities have increased their beneficial ownership in Civeo Corp to 9.9% and are actively engaging with the company to advocate for the appointment of a new independent director to its Board.
NYSE
Activist investor Engine Capital, holding a 9.8% stake in Civeo Corp, has sent a letter to the Board of Directors demanding a drastic shift in capital allocation, including dividend elimination and a large share repurchase tender, alongside a review of strategic alternatives to address significant undervaluation.
NYSE
Engine Capital and its affiliated entities have significantly increased their beneficial ownership in Civeo Corp, now collectively holding 9.4% of the outstanding common shares.

Schedule 13G - Passive Investments

See all →
NYSE
American Century ETF Trust, American Century Investment Management, Inc., American Century Companies, Inc., and Stowers Institute for Medical Research have collectively disclosed beneficial ownership of over 5% of Civeo Corporation's common stock.
NYSE
American Century Investment Management has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in Civeo Corporation.
NYSE
Horizon Kinetics Asset Management LLC has filed an amendment to its Schedule 13G, disclosing a continued beneficial ownership of 21.3% in Civeo Corp's common shares as of December 31, 2025.
NYSE
Dimensional Fund Advisors LP has reported a 5.5% beneficial ownership stake in Civeo Corp's common stock as of December 31, 2025.
NYSE
M Partners Fund LP and its affiliates have reported a 0% beneficial ownership in Civeo Corporation, indicating a full divestment or reduction below reporting thresholds.
Worse than expected
NYSE
M Partners Fund LP, along with its general partner and managing member, has reported a 5.31% beneficial ownership stake in Civeo Corporation's common shares.